Peripheral neuropathy is nerve damage that can cause tingling toes, numb feet, or trouble with balance. It can have many possible causes. Monoclonal gammopathy of undetermined significance (MGUS) and peripheral neuropathy can occur together. But having both conditions doesn’t automatically mean MGUS caused the nerve damage.
MGUS is a condition that can sometimes progress to myeloma or other blood cell cancers. MGUS itself usually doesn’t cause symptoms. But in some people, the abnormal protein made by the condition may affect the nerves.
This article will explain how MGUS and peripheral neuropathy may be connected, what symptoms can occur, how doctors look for the cause, and how neuropathy may be treated and managed.
Researchers have found a connection between MGUS and peripheral neuropathy, but they aren’t quite sure exactly why the two are connected.
In MGUS, altered plasma cells make an abnormal protein called a monoclonal protein, or M protein. Doctors have to determine whether the M protein is actually causing the nerve problem or whether the two conditions happen to occur together.
A 2026 study illustrates why the distinction matters. Among 1,399 people who had monoclonal protein testing during an evaluation for peripheral neuropathy, about 11 percent were found to have a monoclonal gammopathy. However, researchers ultimately attributed the neuropathy to the monoclonal gammopathy in only 0.8 percent of everyone tested.
This is why doctors may look for other possible causes of neuropathy, such as:
For people with myeloma, peripheral neuropathy can also be related to myeloma itself or to some myeloma treatments. The time your symptoms started and how they’ve changed over time can provide important clues.
Certain types of MGUS are more closely linked to neuropathy. Peripheral neuropathy is more common in people with IgM monoclonal gammopathies.
In some people with IgM MGUS, the abnormal IgM antibody reacts with myelin-associated glycoprotein (MAG). MAG is a protein that helps protect nerves. These antibodies are called anti-MAG antibodies.
Anti-MAG neuropathy is one of the most well-known types of nerve damage linked to IgM.
Peripheral neuropathy symptoms depend on which nerves are damaged. Symptoms often start in the feet or hands and may gradually spread farther up the legs or arms.
MGUS neuropathy symptoms may include:
Symptoms can range from mild changes in sensation to problems that interfere with walking or everyday activities, although severe symptoms are rare.
“My first symptom of MGUS was numbness in my toes. My neuropathy spread from my feet to the top of my hips,” one MyMyelomaTeam member said, describing a very rare reaction. “I was so weak I ended up in a wheelchair. I walked with a walker or a cane for several years.”
Tell your healthcare team about new or worsening numbness, weakness, pain, or balance problems, particularly if the symptoms are spreading or changing over time.
Finding the cause of neuropathy can take time, particularly when MGUS, myeloma, myeloma treatments, and other health conditions could all play a role.
There isn’t one test that can prove MGUS is responsible for peripheral neuropathy. Healthcare providers may consider the pattern of nerve symptoms and the type of monoclonal protein. They may also do neurologic testing and look at other possible causes.
There are other blood disorders that can affect nerves. Depending on your symptoms and test results, the evaluation may look for conditions such as:
Distinguishing among these conditions is an important part of evaluating neuropathy in someone with a monoclonal protein. When the connection between MGUS and neuropathy isn’t clear, a hematologist and neurologist may work together.
Keep your hematology and neurology teams updated about when symptoms began and how they’re changing. This can help them determine which tests and treatments make the most sense for you.
Blood testing is commonly part of the diagnostic evaluation for peripheral neuropathy. It can provide more information about MGUS and other possible causes of neuropathy.
Blood tests may also check for other conditions that can contribute to neuropathy, such as diabetes or low vitamin levels, especially vitamin B12 deficiency.
If your doctor thinks you may have an IgM-related neuropathy, your care team may test for anti-MAG antibodies. Doctors interpret anti-MAG antibody results together with a person’s symptoms and nerve-testing results rather than relying on the antibody test alone.
Depending on your symptoms, neurologic testing may include:
These tests may also show whether the main problem involves the nerve fibers themselves or their protective covering, called myelin. IgM-related neuropathies such as anti-MAG neuropathy often produce a pattern of myelin damage.
Most people with MGUS don’t need treatment for MGUS itself. Instead, doctors usually monitor the condition over time with follow-up visits and laboratory testing.
For IgM-associated neuropathy, treatment may be considered when symptoms are progressing or interfering with everyday function. The goal may be to slow or prevent additional nerve damage and, when possible, improve function.
Neurologic improvement may take months or even years after treatment because nerves recover slowly.
Treatment depends on the type of monoclonal protein and the specific neuropathy. Some IgM-related neuropathies may be treated with therapies that target the abnormal B cells producing IgM.
Rituximab is one treatment that has been studied for anti-MAG neuropathy, but clinical trials have produced mixed results.
If doctors find that another condition is causing your neuropathy, treatment is aimed at that condition instead.
Even when the underlying nerve damage can’t be reversed, treatment may help you manage symptoms and stay active. Medicines used for nerve pain and physical therapy may help with movement, weakness, and balance problems.
Reduced sensation can make it harder to notice an injury, particularly on the feet. Make sure to protect areas that have reduced sensation and take steps to reduce the risk of accidents.
Practical steps that may help you manage peripheral neuropathy and stay safe include:
Get updates directly to your inbox.
I have heard that there is something called a M protein inhibitor that can stop the M protein from causing neuropathy. Has anyone heard of
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
I hope it works. I was on Lyica for about a year. But I have now lost almost all feeling in my hands and feet. Nothing worked, so I just deal with it.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.